Entero Healthcare Solutions Limited
Live Updates, GMP, Subscription Data, and Financial Details
IPO Overview
Listed
Dates
Feb 9 to FEB 13, 2024
Price Band
₹1195-1258
Current GMP
₹1228.70 (-2.33%)
Subscription
1.43 times
IPO Details
| IPO Date | February 9, 2024 to February 13, 2024 |
| Listing Date | Friday, February 16, 2024 |
| Face Value | ₹10 per share |
| Price Band | ₹1195 to ₹1258 per share |
| Lot Size | 11 Shares |
| Total Issue Size | 12,718,600 shares (aggregating up to ₹1,600.00 Cr) |
| Fresh Issue | 7,949,125 shares (aggregating up to ₹1,000.00 Cr) |
| Offer for Sale | 4,769,475 shares of ₹10 (aggregating up to ₹600.00 Cr) |
| Employee Discount | Rs 119 per share |
| Issue Type | Book Built Issue IPO |
| Listing At | BSE, NSE |
| Share holding pre issue | 39,577,705 |
| Share holding post issue | 47,526,830 |
IPO Date
February 9, 2024 to February 13, 2024
Listing Date
Friday, February 16, 2024
Face Value
₹10 per share
Price Band
₹1195 to ₹1258 per share
Lot Size
11 Shares
Total Issue Size
12,718,600 shares (aggregating up to ₹1,600.00 Cr)
Fresh Issue
7,949,125 shares (aggregating up to ₹1,000.00 Cr)
Offer for Sale
4,769,475 shares of ₹10 (aggregating up to ₹600.00 Cr)
Employee Discount
Rs 119 per share
Issue Type
Book Built Issue IPO
Listing At
BSE, NSE
Share holding pre issue
39,577,705
Share holding post issue
47,526,830
IPO Subscription Details
| Anchor Investors | 1 |
| Qualified Institutions | 2.29 |
| Non-Institutional Buyers | 0.22 |
| bNII (bids above ₹10L) | 0.17 |
| sNII (bids below ₹10L) | 0.34 |
| Retail Investors | 0.92 |
| Employees | 1.32 |
| Total ** | 1.43 |
Anchor Investors
1
Qualified Institutions
2.29
Non-Institutional Buyers
0.22
bNII (bids above ₹10L)
0.17
sNII (bids below ₹10L)
0.34
Retail Investors
0.92
Employees
1.32
Total **
1.43
Day Wise Sub
| Day | QIB | NII | Retail | EMP | Total |
|---|---|---|---|---|---|
| Day 1 Feb 9, 2024 | 0.00 | 0.04 | 0.32 | 0.36 | 0.09 |
| Day 2 Feb 12, 2024 | 0.00 | 0.09 | 0.62 | 0.83 | 0.18 |
| Day 3 Feb 13, 2024 | 2.29 | 0.22 | 0.92 | 1.32 | 1.43 |
DayDay 1
Feb 9, 2024
QIB0.00
NII0.04
Retail0.32
EMP0.36
Total0.09
DayDay 2
Feb 12, 2024
QIB0.00
NII0.09
Retail0.62
EMP0.83
Total0.18
DayDay 3
Feb 13, 2024
QIB2.29
NII0.22
Retail0.92
EMP1.32
Total1.43
Day Wise GMP
| Date | Price | GMP | Estimate List Price |
|---|---|---|---|
| 16-02-2024 | 1258.00 | 2 (0.16%) | 1260 |
| 15-02-2024 | 1258.00 | 2 (0.16%) | 1260 |
| 14-02-2024 | 1258.00 | 2 (0.16%) | 1260 |
| 13-02-2024 | 1258.00 | 2 (0.16%) | 1260 |
| 12-02-2024 | 1258.00 | 10 (0.79%) | 1268 |
| 11-02-2024 | 1258.00 | 5 (0.4%) | 1263 |
| 10-02-2024 | 1258.00 | 5 (0.4%) | 1263 |
| 09-02-2024 | 1258.00 | 65 (5.17%) | 1323 |
| 08-02-2024 | 1258.00 | 118 (9.38%) | 1376 |
| 07-02-2024 | 1258.00 | 125 (9.94%) | 1383 |
| 06-02-2024 | 1258.00 | 0 (0%) | 1258 |
Date16-02-2024
Price1258.00
GMP2 (0.16%)
Estimate List Price1260
Date15-02-2024
Price1258.00
GMP2 (0.16%)
Estimate List Price1260
Date14-02-2024
Price1258.00
GMP2 (0.16%)
Estimate List Price1260
Date13-02-2024
Price1258.00
GMP2 (0.16%)
Estimate List Price1260
Date12-02-2024
Price1258.00
GMP10 (0.79%)
Estimate List Price1268
Date11-02-2024
Price1258.00
GMP5 (0.4%)
Estimate List Price1263
Date10-02-2024
Price1258.00
GMP5 (0.4%)
Estimate List Price1263
Date09-02-2024
Price1258.00
GMP65 (5.17%)
Estimate List Price1323
Date08-02-2024
Price1258.00
GMP118 (9.38%)
Estimate List Price1376
Date07-02-2024
Price1258.00
GMP125 (9.94%)
Estimate List Price1383
Date06-02-2024
Price1258.00
GMP0 (0%)
Estimate List Price1258
IPO Important Dates
| IPO Open Date | Friday, February 9, 2024 |
| IPO Close Date | Tuesday, February 13, 2024 |
| Basis of Allotment | Wednesday, February 14, 2024 |
| Initiation of Refunds | Thursday, February 15, 2024 |
| Credit of Shares to Demat | Thursday, February 15, 2024 |
| Listing Date | Friday, February 16, 2024 |
| Cut-off time for UPI mandate confirmation | 5 PM on February 13, 2024 |
IPO Open Date
Friday, February 9, 2024
IPO Close Date
Tuesday, February 13, 2024
Basis of Allotment
Wednesday, February 14, 2024
Initiation of Refunds
Thursday, February 15, 2024
Credit of Shares to Demat
Thursday, February 15, 2024
Listing Date
Friday, February 16, 2024
Cut-off time for UPI mandate confirmation
5 PM on February 13, 2024
IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 11 | ₹13,838 |
| Retail (Max) | 14 | 154 | ₹193,732 |
| S-HNI (Min) | 15 | 165 | ₹207,570 |
| S-HNI (Max) | 72 | 792 | ₹996,336 |
| B-HNI (Min) | 73 | 803 | ₹1,010,174 |
ApplicationRetail (Min)
Lots1
Shares11
Amount₹13,838
ApplicationRetail (Max)
Lots14
Shares154
Amount₹193,732
ApplicationS-HNI (Min)
Lots15
Shares165
Amount₹207,570
ApplicationS-HNI (Max)
Lots72
Shares792
Amount₹996,336
ApplicationB-HNI (Min)
Lots73
Shares803
Amount₹1,010,174
Financial Information
| Period Ended | 30 Sep 2023 | 31 Mar 2023 | 31 Mar 2022 |
|---|---|---|---|
| Period Ended | 30 Sep 2023 | 31 Mar 2023 | 31 Mar 2022 |
| Assets | 1,505.95 | 1,308.73 | 1,125.98 |
| Revenue | 1,898.98 | 3,305.72 | 2,526.55 |
| Profit After Tax | 11.64 | -11.10 | -29.44 |
| Net Worth | 660.54 | 597.66 | 563.22 |
| Total Borrowing | 488.68 | 373.52 | 285.03 |
Period EndedPeriod Ended
30 Sep 202330 Sep 2023
31 Mar 202331 Mar 2023
31 Mar 202231 Mar 2022
Period EndedAssets
30 Sep 20231,505.95
31 Mar 20231,308.73
31 Mar 20221,125.98
Period EndedRevenue
30 Sep 20231,898.98
31 Mar 20233,305.72
31 Mar 20222,526.55
Period EndedProfit After Tax
30 Sep 202311.64
31 Mar 2023-11.10
31 Mar 2022-29.44
Period EndedNet Worth
30 Sep 2023660.54
31 Mar 2023597.66
31 Mar 2022563.22
Period EndedTotal Borrowing
30 Sep 2023488.68
31 Mar 2023373.52
31 Mar 2022285.03
Key Performance Indicator
| ROE | -2.66% |
| ROCE | 6.06% |
| Debt/Equity | 0.45 |
| RoNW | -1.86% |
| P/BV | 7.22 |
| EPS (Rs) | 0 |
ROE
-2.66%
ROCE
6.06%
Debt/Equity
0.45
RoNW
-1.86%
P/BV
7.22
EPS (Rs)
0
IPO Reservation
| Investor Category | Shares Offered | Maximum Allottees |
|---|---|---|
| Anchor Investor Shares Offered | 5,694,753 (44.33%) | NA |
| QIB Shares Offered | 3,808,069 (29.65%) | NA |
| NII (HNI) Shares Offered | 1,960,609 (15.26%) | |
| bNII > ₹10L | 1,307,072 (10.18%) | 7,921 |
| sNII < ₹10L | 653,537 (5.09%) | 3,960 |
| Retail Shares Offered | 1,307,073 (10.18%) | 118,824 |
| Employee Shares Offered | 74,349 (0.58%) | NA |
| Total Shares Offered | 12,844,853 (100%) |
Investor CategoryAnchor Investor Shares Offered
Shares Offered5,694,753 (44.33%)
Maximum AllotteesNA
Investor CategoryQIB Shares Offered
Shares Offered3,808,069 (29.65%)
Maximum AllotteesNA
Investor CategoryNII (HNI) Shares Offered
Shares Offered1,960,609 (15.26%)
Maximum Allottees
Investor CategorybNII > ₹10L
Shares Offered1,307,072 (10.18%)
Maximum Allottees7,921
Investor CategorysNII < ₹10L
Shares Offered653,537 (5.09%)
Maximum Allottees3,960
Investor CategoryRetail Shares Offered
Shares Offered1,307,073 (10.18%)
Maximum Allottees118,824
Investor CategoryEmployee Shares Offered
Shares Offered74,349 (0.58%)
Maximum AllotteesNA
Investor CategoryTotal Shares Offered
Shares Offered12,844,853 (100%)
Maximum Allottees
Information about company
Incorporated in 2018, Entero Healthcare Solutions Limited is a distributor of healthcare products in India. The company's technology-driven platform provides healthcare product distribution services to pharmacies, hospitals, and clinics throughout India.
During the fiscal years 2021, 2022, and 2023, the company served over 39,500, 64,200, and 81,400 retail customers, respectively. Additionally, they also served over 1,600, 2,500, and 3,400 hospital customers during the same period.
Entero Healthcare Solutions has relationships with over 1,900 healthcare product manufacturers, giving them access to over 64,500 product stock-keeping units as of March 31, 2023.
The company has 73 warehouses in 37 cities across 19 states and union territories, and its customer base includes over 81,400 pharmacies and 3,400 hospitals in 495 districts as of March 31, 2023. This provides excellent access to healthcare product manufacturers.
As of 31st March, 2023, the company employs a total of 3014 people in various departments.
Disclaimer
All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions.
We are not a SEBI Registered analyst. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on Information published on this application.
No financial information whatsoever published anywhere, within this application, should be considered as advice to buy or sell securities or invest in IPOs, or as a guide to doing so in any way whatsoever
Please read all Tearms and conditions , and agree to use the App